The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Polysomnography


Psychiatry related information on Polysomnography


High impact information on Polysomnography

  • The timing of the production of endogenous melatonin was measured as a marker of the circadian time (phase), and sleep was monitored by polysomnography [11].
  • Data included questionnaire information on medical and family history, SDB symptoms; measurement of height, weight, blood pressure, waist and hip circumference, and serum cholesterol concentration; and overnight sleep monitoring [12].
  • The effect of cyproheptadine on plasma growth hormone and cortisol levels was studied in seven male volunteers with polygraphic sleep monitoring [13].
  • Eighteen clinically stable male schizophrenic patients taking haloperidol were studied with 3 nights of polysomnography for baseline measures and again after neuroleptic withdrawal [14].
  • Social engagement was assessed by questionnaire, sleep was assessed by using the NightCap in-home sleep monitoring system and the Pittsburgh Sleep Quality Index, and blood samples were obtained for analysis of plasma levels of IL-6 [15].

Chemical compound and disease context of Polysomnography


Biological context of Polysomnography


Anatomical context of Polysomnography


Associations of Polysomnography with chemical compounds

  • All-night polysomnography was performed in a sleep laboratory during the last 2 days of placebo treatment and on days 13, 14, 89, and 90 of tenoxicam treatment [27].
  • Plasma levodopa concentrations were measured serially and all-night polysomnography was performed [28].
  • Each subject completed a questionnaire including questions on sleep-related symptoms and underwent overnight polysomnography in which we evaluated the apnea-hypopnea index (AHI) and the percentage of time during which arterial O2 saturation was less than 90% (T90) [29].
  • DESIGN: Patients with OSA were studied by polysomnography during APAP therapy (Somnosmart) [30].
  • The agreement between both strategies, visual and computer analysis, was tested using data from a pharmacological sleep study with 16 elderly insomniacs, which was aimed at comparing the effects of lormetazepam and zopiclone on polysomnography [31].

Gene context of Polysomnography

  • Polysomnography demonstrated that the percentage of SWS was not different when saline and GHRH antagonist nights were compared (P=0.607); other quantifiable sleep parameters were also unchanged [32].
  • A clinical follow-up was performed approximately 1 decade after depressed and psychiatrically "normal" control adolescents, who were now young adults, had undergone baseline serial GH measurements over a 24-hour period on the third night of sleep polysomnography studies [33].
  • After polysomnography, venous blood was collected at 5:00 A.M. from 44 patients with OSAS and 18 control subjects who were obese, and serum levels of MMP-9, TIMP-1, and enzymatic activity of MMP-9 were measured [34].
  • METHODS: Serum and plasma BDNF concentrations, BDNF secretion by peripheral blood mononuclear cells, and overnight polysomnography were evaluated in 17 men with newly diagnosed OSAS (as defined by a respiratory disturbance index of >10/hour with >70% obstructive events and corresponding daytime symptoms) and 12 healthy control men [35].
  • Forty-seven ADHD children referred to the sleep clinic (ADHDcl), 53 ADHD children from a community survey (ADHDcom), and 49 control children underwent overnight polysomnography [36].

Analytical, diagnostic and therapeutic context of Polysomnography


  1. Sleep apnea, narcolepsy, and dreaming: regional cerebral hemodynamics. Meyer, J.S., Sakai, F., Karacan, I., Derman, S., Yamamoto, M. Ann. Neurol. (1980) [Pubmed]
  2. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. Brooks, B., Cistulli, P.A., Borkman, M., Ross, G., McGhee, S., Grunstein, R.R., Sullivan, C.E., Yue, D.K. J. Clin. Endocrinol. Metab. (1994) [Pubmed]
  3. Efficacy of fluticasone nasal spray for pediatric obstructive sleep apnea. Brouillette, R.T., Manoukian, J.J., Ducharme, F.M., Oudjhane, K., Earle, L.G., Ladan, S., Morielli, A. J. Pediatr. (2001) [Pubmed]
  4. Underestimation of nocturnal hypoxemia due to monitoring conditions in patients with COPD. Brijker, F., van den Elshout, F.J., Heijdra, Y.F., Folgering, H.T. Chest (2001) [Pubmed]
  5. Polysomnography in transgenic hSOD1 mice as Down syndrome model. Colas, D., London, J., Cespuglio, R., Sarda, N. J. Neural Transm. Suppl. (2003) [Pubmed]
  6. Vagus nerve stimulation reduces daytime sleepiness in epilepsy patients. Malow, B.A., Edwards, J., Marzec, M., Sagher, O., Ross, D., Fromes, G. Neurology (2001) [Pubmed]
  7. Circadian interleukin-6 secretion and quantity and depth of sleep. Vgontzas, A.N., Papanicolaou, D.A., Bixler, E.O., Lotsikas, A., Zachman, K., Kales, A., Prolo, P., Wong, M.L., Licinio, J., Gold, P.W., Hermida, R.C., Mastorakos, G., Chrousos, G.P. J. Clin. Endocrinol. Metab. (1999) [Pubmed]
  8. Sleep-onset rapid eye movement after electroconvulsive therapy is more frequent in patients who respond less well to electroconvulsive therapy. Grunhaus, L., Shipley, J.E., Eiser, A., Pande, A.C., Tandon, R., Krahn, D.D., Demitrack, M.A., Remen, A., Hirschmann, S., Greden, J.F. Biol. Psychiatry (1997) [Pubmed]
  9. The effect of donepezil on sleep and REM sleep EEG in patients with Alzheimer disease: a double-blind placebo-controlled study. Moraes, W.d.o.s. .S., Poyares, D.R., Guilleminault, C., Ramos, L.R., Bertolucci, P.H., Tufik, S. Sleep. (2006) [Pubmed]
  10. Dose-response effects of tiagabine on the sleep of older adults. Walsh, J.K., Randazzo, A.C., Frankowski, S., Shannon, K., Schweitzer, P.K., Roth, T. Sleep. (2005) [Pubmed]
  11. Entrainment of free-running circadian rhythms by melatonin in blind people. Sack, R.L., Brandes, R.W., Kendall, A.R., Lewy, A.J. N. Engl. J. Med. (2000) [Pubmed]
  12. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. Tishler, P.V., Larkin, E.K., Schluchter, M.D., Redline, S. JAMA (2003) [Pubmed]
  13. Suppression by cyproheptadine of human growth hormone and cortisol secretion during sleep. Chihara, K., Kato, Y., Maeda, K., Matsukura, S., Imura, H. J. Clin. Invest. (1976) [Pubmed]
  14. Sleep in schizophrenic patients on and off haloperidol therapy. Clinically stable vs relapsed patients. Neylan, T.C., van Kammen, D.P., Kelley, M.E., Peters, J.L. Arch. Gen. Psychiatry (1992) [Pubmed]
  15. Social relationships, sleep quality, and interleukin-6 in aging women. Friedman, E.M., Hayney, M.S., Love, G.D., Urry, H.L., Rosenkranz, M.A., Davidson, R.J., Singer, B.H., Ryff, C.D. Proc. Natl. Acad. Sci. U.S.A. (2005) [Pubmed]
  16. Medroxyprogesterone acetate and ethanol-induced exacerbation of obstructive sleep apnea. Collop, N.A. Chest (1994) [Pubmed]
  17. Evaluation of a portable device based on peripheral arterial tone for unattended home sleep studies. Bar, A., Pillar, G., Dvir, I., Sheffy, J., Schnall, R.P., Lavie, P. Chest (2003) [Pubmed]
  18. Accuracy of oximetry for detection of respiratory disturbances in sleep apnea syndrome. Lévy, P., Pépin, J.L., Deschaux-Blanc, C., Paramelle, B., Brambilla, C. Chest (1996) [Pubmed]
  19. Physiological consequences of prolonged periods of flow limitation in patients with sleep apnea hypopnea syndrome. Calero, G., Farre, R., Ballester, E., Hernandez, L., Daniel, N., Montserrat Canal, J.M. Respiratory medicine. (2006) [Pubmed]
  20. Nightcap: a reliable system for determining sleep onset latency. Cantero, J.L., Atienza, M., Stickgold, R., Hobson, J.A. Sleep. (2002) [Pubmed]
  21. C-reactive protein and sleep-disordered breathing. Guilleminault, C., Kirisoglu, C., Ohayon, M.M. Sleep. (2004) [Pubmed]
  22. Sleep quality and daytime function in adults with cystic fibrosis and severe lung disease. Dancey, D.R., Tullis, E.D., Heslegrave, R., Thornley, K., Hanly, P.J. Eur. Respir. J. (2002) [Pubmed]
  23. Sleep-disordered breathing, glucose intolerance, and insulin resistance. Punjabi, N.M., Ahmed, M.M., Polotsky, V.Y., Beamer, B.A., O'Donnell, C.P. Respiratory physiology & neurobiology. (2003) [Pubmed]
  24. Incidence of RBD and hallucination in patients affected by Parkinson's disease: 8-year follow-up. Onofrj, M., Thomas, A., D'Andreamatteo, G., Iacono, D., Luciano, A.L., Di Rollo, A., Di Mascio, R., Ballone, E., Di Iorio, A. Neurol. Sci. (2002) [Pubmed]
  25. Nocturnal oxyhemoglobin desaturation in COPD patients with arterial oxygen tensions above 60 mm Hg. Fletcher, E.C., Miller, J., Divine, G.W., Fletcher, J.G., Miller, T. Chest (1987) [Pubmed]
  26. Sleep development in children with congenital and acquired hypothyroidism. Hayashi, M., Araki, S., Kohyama, J., Shimozawa, K., Iwakawa, Y. Brain Dev. (1997) [Pubmed]
  27. Nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis patients. Lack of association between clinical improvement and effects on sleep. Lavie, P., Nahir, M., Lorber, M., Scharf, Y. Arthritis Rheum. (1991) [Pubmed]
  28. A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Högl, B.E., Gómez-Arévalo, G., García, S., Scipioni, O., Rubio, M., Blanco, M., Gershanik, O.S. Neurology (1998) [Pubmed]
  29. Screening for subclinical sleep-disordered breathing. Scharf, S.M., Garshick, E., Brown, R., Tishler, P.V., Tosteson, T., McCarley, R. Sleep. (1990) [Pubmed]
  30. Auto-CPAP therapy for obstructive sleep apnea: induction of microarousals by automatic variations of CPAP pressure? Fuchs, F.S., Wiest, G.H., Frank, M., Harsch, I.A., Schahin, S.P., Hahn, E.G., Ficker, J.H. Sleep. (2002) [Pubmed]
  31. A comparison between visual and computer assessment of sleep onset latency and their application in a pharmacological sleep study. Jobert, M., Escola, H., Jähnig, P., Schulz, H. Sleep. (1993) [Pubmed]
  32. Blockade of endogenous growth hormone-releasing hormone receptors dissociates nocturnal growth hormone secretion and slow-wave sleep. Jessup, S.K., Malow, B.A., Symons, K.V., Barkan, A.L. Eur. J. Endocrinol. (2004) [Pubmed]
  33. Nocturnal growth hormone secretion studies in adolescents with or without major depression re-examined: integration of adult clinical follow-up data. Coplan, J.D., Wolk, S.I., Goetz, R.R., Ryan, N.D., Dahl, R.E., Mann, J.J., Weissman, M.M. Biol. Psychiatry (2000) [Pubmed]
  34. Increased levels and activity of matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Tazaki, T., Minoguchi, K., Yokoe, T., Samson, K.T., Minoguchi, H., Tanaka, A., Watanabe, Y., Adachi, M. Am. J. Respir. Crit. Care Med. (2004) [Pubmed]
  35. Regulation of brain-derived neurotrophic factor (BDNF) during sleep apnoea treatment. Staats, R., Stoll, P., Zingler, D., Virchow, J.C., Lommatzsch, M. Thorax (2005) [Pubmed]
  36. Sleep disturbances in children with attention deficit hyperactivity disorder. O'Brien, L.M., Ivanenko, A., Crabtree, V.M., Holbrook, C.R., Bruner, J.L., Klaus, C.J., Gozal, D. Pediatr. Res. (2003) [Pubmed]
  37. Evaluation of positive airway pressure treatment for sleep related breathing disorders in adults. Gay, P., Weaver, T., Loube, D., Iber, C. Sleep. (2006) [Pubmed]
  38. Pulmonary arterial hypertension in patients with sleep apnoea syndrome. Bady, E., Achkar, A., Pascal, S., Orvoen-Frija, E., Laaban, J.P. Thorax (2000) [Pubmed]
  39. Narcolepsy-like symptoms in a patient with down syndrome and without obstructive sleep apnea. Dominguez-Ortega, L., Salin-Pascual, R.J., Díaz-Gállego, E. Sleep. (2003) [Pubmed]
  40. L-dopa therapy of uremic and idiopathic restless legs syndrome: a double-blind, crossover trial. Trenkwalder, C., Stiasny, K., Pollmächer, T., Wetter, T., Schwarz, J., Kohnen, R., Kazenwadel, J., Krüger, H.P., Ramm, S., Künzel, M. Sleep. (1995) [Pubmed]
  41. Sleep and apnea in the elderly: reliability and validity of 24-hour recordings in the home. Acebo, C., Watson, R.K., Bakos, L., Thoman, E.B. Sleep. (1991) [Pubmed]
WikiGenes - Universities